A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Preliminary Efficacy Study of IC14 in Acute Respiratory Distress Syndrome

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Preliminary Efficacy Study of IC14 in Acute Respiratory Distress Syndrome

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs IC 14 (Primary)
  • Indications Respiratory distress syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Implicit Bioscience
  • Most Recent Events

    • 13 Jan 2017 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
    • 13 Jan 2017 Planned primary completion date changed from 1 Apr 2019 to 1 Jun 2020.
    • 13 Jan 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top